The 2011 Leading Life Science Intermediates Companies Comparative Analysis

October 2010 | 5 pages | ID: LFA15867F13EN
Venture Planning Group

Abstracts

Global PDF: US$ 1,900.00

This report ranks the world’s major life science intermediates companies according to the following criteria:

• Estimated sales in Europe, North America, Asia, and other geographic regions.
• Operating profit.
• R&D expenditures.

The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep, and Rhodia.

Contains 5 pages and 4 tables